학술논문
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Document Type
Article
Author
Gronchi, A.; Palassini, E.; Stacchiotti, S.; Casali, P.G.; Morosi, C.; Ferrari, S.; Palmerini, E.; Marchesi, E.; Donati, D.M.; Picci, P.; Quagliuolo, V.; De Sanctis, R.; Broto, J.M.; Pousa, A.L.; Bagué, S.; Grignani, G.; Basso, U.; Blay, J.-Y.; Tendero, O.; Beveridge, R.D.; Ferraresi, V.; Lugowska, I.; Merlo, D.F.; Fontana, V.; Bruzzi, P.; Coindre, J.M.; Dei Tos, A.P.
Source
In: The Lancet Oncology . (The Lancet Oncology, June 2017, 18(6):812-822)
Subject
Language
English
ISSN
14745488
14702045
14702045